ABSTRACT
INTRODUCTION
Cervical spondylotic myelopathy (CSM) is a well-known clinical syndrome of multifactorial origin and is the most common acquired cause of spinal cord disease
(1) . Risk factors believed to be most important for the development of CSM are canal stenosis beyond a critical size, extent of spinal cord compression, and dynamic mechanical factors such as axial tension during stretching over the anterior osteophytes (2) . Although spinal canal stenosis with reduction of the anteroposterior diameter of the spinal cord has been proven to be a major risk factor of CSM (3) , recent studies suggest that not every patient with spinal canal stenosis or carriers of other risk factors develop CSM. Instead, only a small fraction of these patients will develop symptoms of CSM
(4)
. Beyond the proven risk factors, genetic factors have been supposed to be responsible for the development of CSM. One of those genes which are associated with the development of neurologic diseases is the apolipoprotein E gene (Apo E) (5) . Apolipoprotein E is a multifunctional protein with central roles in lipid metabolism and neurobiology. It has three common isoforms (apoE2, apoE3, and apoE4) with different effects on lipid and neuronal homeostasis (6,7) . The Apo E gene, located on chromosome 19, is composed of three alleles (E2, E3 and E4) that give rise to six different genotypes (E2/2, E2/3, E2/4, E3/3, E3/4, and E4/4) .The three alleles differ in their frequencies: E4 (15-20%), E3 (65-70%), and E2 (5-10%). The E3 allele differs from the E2 allele by an amino acid substitution of arginine for cysteine at codon 158, while the E4 differs from E3 by a substitution of arginine for cysteine at residue 112 (8,9) . Neuronal expression of ApoE has been controversial. It is produced by several types of cells in the central nervous system, including astrocytes (10) and activated microglia (11) . Neuron-derived apoE3 and apoE4 differ in their susceptibility to proteolysis and in their effects on mitochondrial function, tau phosphorylation, lysosomal leakage, neurodegeneration, androgen receptor deficiency, and cognitive decline (12,13) . In apoE4, Arg-112 orients the side chain of Arg-61 into the aqueous environment where it can interact with Glu-255, resulting in interaction between the N-and C-terminal domains. In apoE3, Arg-61 is not available to interact with glutamic acid-255 (14) . ApoE4 contributes to neuropathology by interacting with the amyloid pathway to modulate amyloid β (Aβ) peptide synthesis or clearance (15) . Also, ApoE4 synthesized by neurons undergoes proteolytic cleavage to a much greater extent than apoE3. The resulting fragments with C-terminal truncations escape the secretory pathway and enter the cytosol. Most of these fragments are neurotoxic (12).
Thus, the aim of the present study is to find Apo E gene expression role in spinal cord compression patients and the possible relationship of polymorphisms of apolipoprotein E (ApoE) gene with occurrence of cervical spondylotic myelopathy (CSM) in these patients.
SUBJECTS & METHODS

Subjects:
The present study was carried out on 60 subjects with chronic spinal cord compression with and without cervical spondylotic myelopathy (CSM). The patients were selected from the Orthopedics Surgery Clinics and Inpatients, Menoufiya University Hospitals in the period from Jan to July-2010. The study was approved by the ethics committee of our institute. The subjects were divided into two groups:
Group (16) . The scale assess motor dysfunction of the upper extremities (0-5 scores) and lower extremities (0-7 scores), as well as sensory dysfunction of the upper extremities (0-3 scores), in addition to sphincter dysfunction (0-3 scores).
The maximum score is 18 which denote absence of any motor, sensory or sphincter dysfunction. However, we also considered additional minor clinical signs of cervical myelopathy. Patients were excluded if they had other central or peripheral neurological conditions or subjected to previous cervical spine surgery and/or trauma. Patients under the age of 18 years were also excluded.
All subjects were submitted to full history taking, general clinical examination.
Clinical variables considered were age in years, number of affected segments, duration of symptoms in months, functional outcome (mJOA score). The diameter of the spinal canal was measured on MRI images and laboratory investigations including genotyping of the studied subjects for two polymorphisms of the apolipoprotein E gene using the PCR-RFLP (restriction fragment length polymorphism) technique was performed.
Sample Collection and assay: After 10 hours overnight fasting, six ml of venous blood were withdrawn from every fasting subject by sterile vein-puncture, and were transferred into EDTA containing tube and used for lymphocyte separation for further molecular analysis.
Lymphoflot solution (Ficol) was used in which lymphoflot has a higher density than that of platelets, lymphocytes or monocytcs, but a lower density than that of erythrocytes and granulocytes. Diluted blood with equal volume of saline is layered into the density gradient (Lymphoflot), during the centrifugation process, erythrocytes and granulocytes pass through the density gradient medium because of their higher density, whereas platelets, lymphocytes and monocytes settle above the density gradient on account of their lower density. The platelets were removed by means of two successive washing procedures with saline then lymphocytes were mixed with 1ml phosphate buffer solution and stored in cryotubes at -80 0 C till analysis (Bio test AG, Dreieich, Germany). DNA from lymphocytes samples was isolated using the Qiagen extraction kit (Hilden, Germany), DNA eluted in buffer AE was stored at -20 0 C for further PCR procedure.
PCR for the apolipoprotein E gene polymorphism was done as follows, PCR was carried out to a total volume of 25 μl, containing 10 μl of genomic DNA, 0.25 μl of each primer (50μM) (Midland, Texas), 2.5 μl of 10x Taq polymerase buffer (25 mM MgCl 2 ) (Qiagen Hilden, Germany), 0.25 μl of AmpliTaq DNA polymerase (5units/μl) (QIAGEN Hilden, Germany), 0.5 μl of dNTPs (10mM) (Qiagen Hilden, Germany), 3 ul of DMSO and 8.25 μl of H 2 O.
The apolipoprotein E gene polymorphism was analyzed using the following primers PCR amplification for polymorphisms was performed in a programmable thermal cycler Perkin Elmer thermal cycler 2400 (USA). One cycle at 94ºC for 5 minutes followed by 40 cycles at 94ºC for 1 minute; 60ºC for 1.5 minute; 72 ºC for 1.5 minute; and one final cycle of extension at 72ºC for 7 minutes. The amplification products were separated by electrophoresis through 3% agarose gel stained with ethidium bromide. The length of the expected target is 218 bp. Ladder of 100 bp was used. The PCR products at 218 bp for the apolipoprotein E gene polymorphism were mixed with 10 units of HaeII restriction enzyme (provided by Biolabs, New England) and 2.5 units of Afl III (provided by Biolabs, New England). The reaction conditions were, 6.25μl nuclease-free water, 2.5μl 10XBuffer 3, 15 μl PCR product, 2.5μl 100X BSA buffer, 0.5ul (10 units) Hae II and 0.5μl (2.5units) Afl III. The reaction was incubated at 37°C over night then 25μl of the products was loaded into a 3% agarose gel containing ethidium bromide for electrophoresis and, the agarose gel was visualized under UV light (17) . Statistical analysis: Results were collected, tabulated, statistically analyzed by IBM personal computer and SPSS version 11. Chi-square test (χ 2 ): was used to study association between two qualitative variables. Odds ratio describe the probability that people who are exposed to a certain factor will have a disease compared to people who are not exposed to the factor. Student unpaired t-test was used for comparison between two groups having quantitative variables. Multiple regression analysis calculates the effects of risk factors as independent Odds ratios with the effects of other confounders removed. P-value of < 0.05 was considered statistically significant.
RESULTS
The results of the present study are presented in tables (1-5) and figures (1-3). This table shows significant increase in the mean of age in years (P< 0.05), duration of symptoms in months and number of affected segments (P<0001) in patients with CSM when compared to non CSM and a significant decrease for the mean of the diameter of spinal canal in millimeter (P<0.001). However, there was shows no significant difference between patients with CSM and non CSM as regarding gender distribution (P> 0.05). This table presents that the Apo E alleles only E 4 shows a significant association with CSM (P< 0.05), whereas no statistically significant differences in the distribution of E 2 and E 3 alleles between patients with CSM and non CSM (P> 0.05). 
RFLP analysis for the ApoE polymorphism:
Simultaneous digestion of 218 bp by Hae II and Afl III restriction enzymes analysis showing the genotypes of the Apo E polymorphism, separated on a 3% agarose gel. The fragments were 145bp band indicating the E3 genotype, the 168bp indicating the E2 genotype and 195bp bands indicating the E4 genotype (digestion products). The molecular marker is a 100 bp ladder (figure 2). 
Surgical procedure:
All patients underwent a single or multilevel anterior surgical decompression and fusion. The standard procedure was disscectomy with subsequent implantation of a cage and autogenous bone graft in 1 or more segments. 41 single level disscectomies and 19 multilevel disscectomies with cervical fusion were performed. Examples of the cases before and after operation are shown in figures 2 and 3. The present study showed that there was no significant difference in sex distribution among the two studied groups, while there was significant difference in age among the same groups. These results are in accordance with the study of Setzer et al., (5) who found a significant differences between CSM and non CSM patients for the age distribution.
DISCUSSION
As regards to the risk factors for cervical spondylotic myelopathy, By applying multivariate regression analysis, this study revealed that duration of symptom (OR was 1.2, 95% CI 0.5 -1.4) , number of affected segments (OR 1.8, 95% CI 0.7-2.2) and diameter of spinal canal (OR 2.4, 95% CI 0.9 -3.6) are independent risk factors of cervical spondylotic myelopathy. These results are matched with the study of Setzer et al. ( 
5)
who found a significant difference between CSM and non CSM patients for the diameter of the cervical spinal canal, for the duration of CSM and non-CSM symptoms, and for the number of affected segments.
A highly significant difference as regards apolipoprotein genotype distribution was found on comparing the two studied groups with increased frequency of the E4/E4 and E3/E4 genotype in group II. There was also increased frequency of the E4 allele in the cervical spondylotic myelopathy patients.
The current study revealed that the E4 allele of the apolipoprotein E polymorphism had significantly increased risk of cervical spondylotic myelopathy (OR 3.2; 95% CI 1.3 -9.8). This is matched with a recent hospital-based study of Setzer et al. (5) who found that the ApoE genotype is associated with the development of CSM in patients with chronic cervical spinal cord compression in the way that patients with CSM are more frequently carriers of the ApoE allele E4 than those with cervical canal stenosis without CSM, and thus E4 might also be a risk factor for the development of CSM. Also, our results agree with those of Setzer et al.
(35) who showed that the carriers of ApoE E4 allele have a higher risk for non improvement after surgical decompression and stabilization.
The present study is in accordance also with the study of Seitz et al., 2003
(36) and 2005 (37) who stated that ApoE is upregulated and is associated in chronic regenerative processes after spinal cord injury.
The present study agrees also with Leung et al.
(38) who stated that the E4 allele seems to a "susceptibility" factor which increases the risk of several neurologic diseases and worsens the prognosis in others.
However The reason for that relationship is unclear, but it is thought that the E4 mutation might involved in chronic reactive/regenerative processes after neurological lesions (40) . ApoE4 can cause neuropathology directly. ApoE4 also sets as the stage for "second hits" to precipitate neuropathology. These second hits may be genetic (as Parkinson's disease), metabolic (ischemia and oxidative stress), or environmental (aging, inflammation, and central nervous system trauma) (7) .
CONCLUSION
It can be concluded that E4 polymorphism of the ApoE gene is associated with the susceptibility to CSM in spinal cord compression and that, longer duration of symptoms, smaller diameter of spinal canal and more number of affected segments are risk factors for such complication. The presence of the ApoE E4 allele is an independent predictor for presence of CSM. However, the results of the current study are preliminary since the size of the cohort is rather small. Therefore, a larger cohort is needed to confirm the association of APOE gene polymorphism and occurrence of CSM in patients with spinal cord compression. Further studies are needed to evaluate the type of ApoE polymorphism in patients with improvement or no improvement after surgery. 
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